RDYDr. Reddy's Laboratories Limited American Depositary Shares

ADRCNew York Stock Exchange (XNYS)·USD

Identity

Security key: 20858
Ticker: RDY
Type: ADRC — American Depository Receipt Common
Exchange: New York Stock Exchange(XNYS)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 2001-04-11
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: RDY

Detail

Enriched 2026-08-14 20:47

Market cap: $10,320,870,904.47
Shares outstanding (class): 834,666,635
Shares outstanding (weighted): 833,000,073
SIC: —
Employees: 27,527
Location: —
Homepage: https://www.drreddys.com
Description: Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Market cap and share counts drift.

Funds holding this security

21 funds · 21 positions · $77.77M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
AB Emerging Markets Opportunities ETF AB Active ETFs, Inc.	EMOP	$32.16M	2.37%	2,321,894 NS	FIGI
State Street(R) SPDR(R) Portfolio Emerging Mark… SPDR INDEX SHARES FUNDS	SPEM	$20.57M	0.13%	1,484,840 NS	FIGI
SIT Emerging Markets Equity Fund SEI INSTITUTIONAL INTERNATIONAL TRUST	—	$7.28M	0.47%	525,686 NS	FIGI
Templeton Developing Markets Trust Templeton Developing Markets Trust	—	$6.78M	0.33%	489,809 NS	FIGI
Mercer Emerging Markets Equity Fund Mercer Funds	—	$2.15M	0.17%	155,293 NS	FIGI
State Street(R) SPDR(R) MSCI ACWI ex-US ETF SPDR INDEX SHARES FUNDS	CWI	$1.45M	0.06%	104,394 NS	FIGI
State Street(R) SPDR(R) Portfolio MSCI Global S… SPDR INDEX SHARES FUNDS	SPGM	$1.39M	0.10%	100,232 NS	FIGI
Nomura Focused Emerging Markets Equity ETF Nomura ETF Trust	EMEQ	$1.22M	0.40%	88,384 NS	FIGI
Templeton Developing Markets VIP Fund Franklin Templeton Variable Insurance Produ…	—	$965.7K	0.28%	69,726 NS	FIGI
RBC Emerging Markets ex-China Equity Fund RBC Funds Trust	—	$824.1K	1.19%	59,500 NS	FIGI
State Street(R) SPDR(R) S&P Kensho New Economie… SPDR SERIES TRUST	KOMP	$681.4K	0.03%	49,200 NS	FIGI
SA Emerging Markets Value Fund SA FUNDS INVESTMENT TRUST	—	$548.1K	0.25%	39,575 NS	FIGI
The Emerging Markets Portfolio HC Capital Trust	—	$495.6K	0.07%	35,786 NS	FIGI
Shelton Emerging Markets Fund SCM Trust	—	$394.7K	1.69%	28,500 NS	FIGI
Total International Ex U.S. Index Master Portfo… Master Investment Portfolio	—	$312.8K	0.01%	22,585 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERRDY
FIGI_COMPOSITEBBG000NJ96L6
FIGI_SHARE_CLASSBBG001SHMCN3
CIK0001135951
ISINUS2561352038
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Dr. Reddy's Laboratories is a pharmaceutical company, so it falls under healthcare and pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.